Use of Chinese herbal medicine 'meizitanc' in pregnancy: Report of three cases

Journal of Obstetrics and Gynaecology Research

Volumn 35, Issue 4, 2009, Pages 801-803

  Çayan, Filiz ^a   Dilek, Umut ^a   Akbay, Esen ^a   Gen, Ramazan ^a   Dilek, Saffet ^a  

^a MERSIN UNIVERSITY   (Turkey)

Author keywords

Contamination; Herbal medicine; Meizitanc; Pregnancy; Toxic metals

Indexed keywords

CHINESE DRUG; MEIZITANC; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CASE REPORT; CHINESE MEDICINE; CURETTAGE; DRUG USE; FEMALE; FETUS HEART; FOLLOW UP; HEART CONTRACTION; HUMAN; MISSED ABORTION; PREGNANCY; PREGNANCY TERMINATION; WEIGHT REDUCTION;

ABORTION, MISSED; ADULT; DRUGS, CHINESE HERBAL; FEMALE; HUMANS; PREGNANCY;

EID: 70049096611     PISSN: 13418076     EISSN: 14470756     Source Type: Journal    
DOI: 10.1111/j.1447-0756.2008.01004.x     Document Type: Article

References (13)

1. Ernst E. Adulteration of Chinese herbal medicines with synthetic drugs: a systematic review. J Intern Med 2002 252 : 107 113.
2. Metcalfe K, Corns C, Fahie-Wilson M, Mackenzie P. Chinese medicines for slimming still cause health problems. BMJ 2002 324 : 679.
3. Jung J, Hermanna-Clausen M, Weinmann W. Anorectic sibutramine detected in a Chinese herbal drug for weight loss. Forensic Sci Int 2006 161 : 221 222.
4. Vidal C, Quandte S. Identification of a sibutramine-metabolite in patient urine after intake of a 'pure herbal' Chinese slimming product. Ther Drug Monit 2006 28 : 690.
5. Florentin M, Liberopoulos EN, Elisaf MS. Sibutramine-associated adverse effects: a practical guide for its safe use. Obes Rev 2008 9 : 378 387.
6. De Santis M, Straface G, Cavaliere AF, Carducci B, Caruso A. Early first trimester sibutramine exposure: pregnancy outcome and neonatal follow-up. Drug Safe 2006 29 : 255 259.
7. Ramzi F, Elias D, Mona S, Zreik T. Sibutramine in pregnancy. Eur J Obstet Gynecol Reprod Biol 2005 122 : 243 251.
8. Wiergowski M, Galer-Tatarowicz K, Nowak-Banasik L et al. Hazard for human health and life by unintentional use of synthetic sibutramine, which was sold as Chinese herbal product 'meizitanc'. Przegl Lek 2007 64 : 268 272.
9. Khattak S, K-Moghtader G, McMartin K, Barrera M, Kennedy D, Koren G. Pregnancy outcome following gestational exposure to organic solvents: a prospective controlled study. JAMA 1999 281 : 1106 1109. (Pubitemid 29155887)
10. Hrubá D, Kukla L, Tyrlík M. Occupational risks for human reproduction: ELSPAC Study. European Longitudinal Study of Pregnancy and Childhood. Cent Eur J Public Health 1999 7 : 210 215.
11. Taskinen H, Kyyrönen P, Hemminki K, Hoikkala M, Lajunen K, Lindbohm ML. Laboratory work and pregnancy outcome. J Occup Med 1994 36 : 311 319.
12. Brown-Woodman PD, Webster WS, Picker K, Ritchie HE. Embryotoxicity of xylene and toluene: an in vitro study. Ind Health 1991 29 : 139 152.
13. Bowen SE, Hannigan JH. Developmental toxicity of prenatal exposure to toluene. AAPS J 2006 8 : E419 E424.